Siemens Healthineers AG
Siemens Healthineers AG (SMMNY) Stock Competitors & Peer Comparison
See (SMMNY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SMMNY | $20.44 | -1.97% | 92B | 18.58 | $1.10 | +1.79% |
| SEMHF | $42.06 | -0.86% | 47B | 19.21 | $2.19 | +2.07% |
| RYLPF | $26.46 | +0.01% | 25.2B | 24.50 | $1.08 | +3.61% |
| SNNUF | $16.05 | +0.00% | 13.6B | 22.29 | $0.72 | +3.88% |
| SONVY | $43.15 | -0.53% | 12.9B | 19.53 | $2.21 | +2.49% |
| SONVF | $214.70 | +2.95% | 12.8B | 19.43 | $11.05 | +2.53% |
| CHEOF | $119.01 | +1.88% | 7.8B | 28.96 | $4.11 | +2.47% |
| CHEOY | $58.29 | +2.95% | 7.6B | 31.49 | $1.85 | +2.25% |
| WILLF | $28.30 | +0.00% | 6B | 16.26 | $1.74 | N/A |
| WILYY | $13.45 | +0.00% | 5.9B | 15.46 | $0.87 | N/A |
Stock Comparison
SMMNY vs SEMHF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SEMHF has a market cap of 47B. Regarding current trading prices, SMMNY is priced at $20.44, while SEMHF trades at $42.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SEMHF's P/E ratio is 19.21. In terms of profitability, SMMNY's ROE is +0.11%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, SMMNY is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check SEMHF's competition here
SMMNY vs RYLPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, RYLPF has a market cap of 25.2B. Regarding current trading prices, SMMNY is priced at $20.44, while RYLPF trades at $26.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas RYLPF's P/E ratio is 24.50. In terms of profitability, SMMNY's ROE is +0.11%, compared to RYLPF's ROE of +0.08%. Regarding short-term risk, SMMNY is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check RYLPF's competition here
SMMNY vs SNNUF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SNNUF has a market cap of 13.6B. Regarding current trading prices, SMMNY is priced at $20.44, while SNNUF trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SNNUF's P/E ratio is 22.29. In terms of profitability, SMMNY's ROE is +0.11%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, SMMNY is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check SNNUF's competition here
SMMNY vs SONVY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SONVY has a market cap of 12.9B. Regarding current trading prices, SMMNY is priced at $20.44, while SONVY trades at $43.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SONVY's P/E ratio is 19.53. In terms of profitability, SMMNY's ROE is +0.11%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, SMMNY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check SONVY's competition here
SMMNY vs SONVF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SONVF has a market cap of 12.8B. Regarding current trading prices, SMMNY is priced at $20.44, while SONVF trades at $214.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SONVF's P/E ratio is 19.43. In terms of profitability, SMMNY's ROE is +0.11%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, SMMNY is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check SONVF's competition here
SMMNY vs CHEOF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CHEOF has a market cap of 7.8B. Regarding current trading prices, SMMNY is priced at $20.44, while CHEOF trades at $119.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CHEOF's P/E ratio is 28.96. In terms of profitability, SMMNY's ROE is +0.11%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, SMMNY is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check CHEOF's competition here
SMMNY vs CHEOY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CHEOY has a market cap of 7.6B. Regarding current trading prices, SMMNY is priced at $20.44, while CHEOY trades at $58.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CHEOY's P/E ratio is 31.49. In terms of profitability, SMMNY's ROE is +0.11%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, SMMNY is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CHEOY's competition here
SMMNY vs WILLF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, WILLF has a market cap of 6B. Regarding current trading prices, SMMNY is priced at $20.44, while WILLF trades at $28.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas WILLF's P/E ratio is 16.26. In terms of profitability, SMMNY's ROE is +0.11%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, SMMNY is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check WILLF's competition here
SMMNY vs WILYY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, WILYY has a market cap of 5.9B. Regarding current trading prices, SMMNY is priced at $20.44, while WILYY trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas WILYY's P/E ratio is 15.46. In terms of profitability, SMMNY's ROE is +0.11%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, SMMNY is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check WILYY's competition here
SMMNY vs GNGBF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, SMMNY is priced at $20.44, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, SMMNY's ROE is +0.11%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, SMMNY is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check GNGBF's competition here
SMMNY vs GNGBY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, GNGBY has a market cap of 5.3B. Regarding current trading prices, SMMNY is priced at $20.44, while GNGBY trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas GNGBY's P/E ratio is 21.74. In terms of profitability, SMMNY's ROE is +0.11%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, SMMNY is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check GNGBY's competition here
SMMNY vs AMBFF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, AMBFF has a market cap of 3.7B. Regarding current trading prices, SMMNY is priced at $20.44, while AMBFF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas AMBFF's P/E ratio is 42.66. In terms of profitability, SMMNY's ROE is +0.11%, compared to AMBFF's ROE of +0.09%. Regarding short-term risk, SMMNY is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check AMBFF's competition here
SMMNY vs NHNKY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, NHNKY has a market cap of 2.9B. Regarding current trading prices, SMMNY is priced at $20.44, while NHNKY trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas NHNKY's P/E ratio is 13.04. In terms of profitability, SMMNY's ROE is +0.11%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, SMMNY is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check NHNKY's competition here
SMMNY vs MCRPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, MCRPF has a market cap of 2.9B. Regarding current trading prices, SMMNY is priced at $20.44, while MCRPF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas MCRPF's P/E ratio is -17.44. In terms of profitability, SMMNY's ROE is +0.11%, compared to MCRPF's ROE of -0.27%. Regarding short-term risk, SMMNY is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check MCRPF's competition here
SMMNY vs AMBBY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, AMBBY has a market cap of 2.7B. Regarding current trading prices, SMMNY is priced at $20.44, while AMBBY trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas AMBBY's P/E ratio is 32.24. In terms of profitability, SMMNY's ROE is +0.11%, compared to AMBBY's ROE of +0.09%. Regarding short-term risk, SMMNY is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check AMBBY's competition here
SMMNY vs NHNKF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, SMMNY is priced at $20.44, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, SMMNY's ROE is +0.11%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, SMMNY is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check NHNKF's competition here
SMMNY vs GNNDY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, SMMNY is priced at $20.44, while GNNDY trades at $43.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas GNNDY's P/E ratio is 20.83. In terms of profitability, SMMNY's ROE is +0.11%, compared to GNNDY's ROE of +0.06%. Regarding short-term risk, SMMNY is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check GNNDY's competition here
SMMNY vs DRWKF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, SMMNY is priced at $20.44, while DRWKF trades at $109.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DRWKF's P/E ratio is 12.70. In terms of profitability, SMMNY's ROE is +0.11%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, SMMNY is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check DRWKF's competition here
SMMNY vs GGNDF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, GGNDF has a market cap of 2B. Regarding current trading prices, SMMNY is priced at $20.44, while GGNDF trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas GGNDF's P/E ratio is 19.64. In terms of profitability, SMMNY's ROE is +0.11%, compared to GGNDF's ROE of +0.06%. Regarding short-term risk, SMMNY is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check GGNDF's competition here
SMMNY vs FDMDF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, FDMDF has a market cap of 1.8B. Regarding current trading prices, SMMNY is priced at $20.44, while FDMDF trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas FDMDF's P/E ratio is -11.29. In terms of profitability, SMMNY's ROE is +0.11%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, SMMNY is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check FDMDF's competition here
SMMNY vs OSSFF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, SMMNY is priced at $20.44, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, SMMNY's ROE is +0.11%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, SMMNY is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check OSSFF's competition here
SMMNY vs DWRKF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, SMMNY is priced at $20.44, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, SMMNY's ROE is +0.11%, compared to DWRKF's ROE of N/A. Regarding short-term risk, SMMNY is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check DWRKF's competition here
SMMNY vs STSEY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, SMMNY is priced at $20.44, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas STSEY's P/E ratio is 19.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, SMMNY is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check STSEY's competition here
SMMNY vs MEDGF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, SMMNY is priced at $20.44, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, SMMNY's ROE is +0.11%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, SMMNY is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check MEDGF's competition here
SMMNY vs OSSUY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, SMMNY is priced at $20.44, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, SMMNY's ROE is +0.11%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, SMMNY is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check OSSUY's competition here
SMMNY vs VTRLY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, SMMNY is priced at $20.44, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VTRLY's P/E ratio is -2.77. In terms of profitability, SMMNY's ROE is +0.11%, compared to VTRLY's ROE of -0.42%. Regarding short-term risk, SMMNY is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check VTRLY's competition here
SMMNY vs DGWPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DGWPF has a market cap of 1.5B. Regarding current trading prices, SMMNY is priced at $20.44, while DGWPF trades at $76.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DGWPF's P/E ratio is 8.89. In terms of profitability, SMMNY's ROE is +0.11%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, SMMNY is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check DGWPF's competition here
SMMNY vs MDRSF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, SMMNY is priced at $20.44, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, SMMNY's ROE is +0.11%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, SMMNY is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check MDRSF's competition here
SMMNY vs ELEAF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, SMMNY is priced at $20.44, while ELEAF trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ELEAF's P/E ratio is 23.06. In terms of profitability, SMMNY's ROE is +0.11%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, SMMNY is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check ELEAF's competition here
SMMNY vs LFTSF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, SMMNY is priced at $20.44, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, SMMNY's ROE is +0.11%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, SMMNY is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check LFTSF's competition here
SMMNY vs XVIPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, SMMNY is priced at $20.44, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas XVIPF's P/E ratio is 212.78. In terms of profitability, SMMNY's ROE is +0.11%, compared to XVIPF's ROE of +0.01%. Regarding short-term risk, SMMNY is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check XVIPF's competition here
SMMNY vs AVMR Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, SMMNY is priced at $20.44, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas AVMR's P/E ratio is -18.34. In terms of profitability, SMMNY's ROE is +0.11%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, SMMNY is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check AVMR's competition here
SMMNY vs DMTRF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, SMMNY is priced at $20.44, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, SMMNY is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check DMTRF's competition here
SMMNY vs BRSYF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, BRSYF has a market cap of 475.2M. Regarding current trading prices, SMMNY is priced at $20.44, while BRSYF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas BRSYF's P/E ratio is 74.19. In terms of profitability, SMMNY's ROE is +0.11%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, SMMNY is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check BRSYF's competition here
SMMNY vs IOBCF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, IOBCF has a market cap of 439.6M. Regarding current trading prices, SMMNY is priced at $20.44, while IOBCF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas IOBCF's P/E ratio is 22.39. In terms of profitability, SMMNY's ROE is +0.11%, compared to IOBCF's ROE of +0.15%. Regarding short-term risk, SMMNY is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check IOBCF's competition here
SMMNY vs CALZF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CALZF has a market cap of 414.5M. Regarding current trading prices, SMMNY is priced at $20.44, while CALZF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CALZF's P/E ratio is 60.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, SMMNY is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CALZF's competition here
SMMNY vs CLVSF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CLVSF has a market cap of 384.8M. Regarding current trading prices, SMMNY is priced at $20.44, while CLVSF trades at $16.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CLVSF's P/E ratio is 23.38. In terms of profitability, SMMNY's ROE is +0.11%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, SMMNY is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CLVSF's competition here
SMMNY vs CSSPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CSSPF has a market cap of 384.5M. Regarding current trading prices, SMMNY is priced at $20.44, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, SMMNY is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CSSPF's competition here
SMMNY vs HYBT Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, SMMNY is priced at $20.44, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas HYBT's P/E ratio is N/A. In terms of profitability, SMMNY's ROE is +0.11%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, SMMNY is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check HYBT's competition here
SMMNY vs CYBQY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CYBQY has a market cap of 338.8M. Regarding current trading prices, SMMNY is priced at $20.44, while CYBQY trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CYBQY's P/E ratio is -190.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, SMMNY is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CYBQY's competition here
SMMNY vs HTLZF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, SMMNY is priced at $20.44, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, SMMNY's ROE is +0.11%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, SMMNY is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check HTLZF's competition here
SMMNY vs CYBQF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CYBQF has a market cap of 229.5M. Regarding current trading prices, SMMNY is priced at $20.44, while CYBQF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CYBQF's P/E ratio is -172.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, SMMNY is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CYBQF's competition here
SMMNY vs IMPZY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, IMPZY has a market cap of 200.8M. Regarding current trading prices, SMMNY is priced at $20.44, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, SMMNY's ROE is +0.11%, compared to IMPZY's ROE of +13.22%. Regarding short-term risk, SMMNY is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check IMPZY's competition here
SMMNY vs VMTHF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VMTHF has a market cap of 184.7M. Regarding current trading prices, SMMNY is priced at $20.44, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VMTHF's P/E ratio is -2.01. In terms of profitability, SMMNY's ROE is +0.11%, compared to VMTHF's ROE of -0.30%. Regarding short-term risk, SMMNY is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check VMTHF's competition here
SMMNY vs DTXMF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, SMMNY is priced at $20.44, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, SMMNY's ROE is +0.11%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, SMMNY is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check DTXMF's competition here
SMMNY vs PXMBF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, SMMNY is priced at $20.44, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, SMMNY's ROE is +0.11%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, SMMNY is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check PXMBF's competition here
SMMNY vs EKDHF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, EKDHF has a market cap of 146.7M. Regarding current trading prices, SMMNY is priced at $20.44, while EKDHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas EKDHF's P/E ratio is 33.98. In terms of profitability, SMMNY's ROE is +0.11%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, SMMNY is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check EKDHF's competition here
SMMNY vs CLLKF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CLLKF has a market cap of 140.2M. Regarding current trading prices, SMMNY is priced at $20.44, while CLLKF trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CLLKF's P/E ratio is -0.85. In terms of profitability, SMMNY's ROE is +0.11%, compared to CLLKF's ROE of -0.50%. Regarding short-term risk, SMMNY is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CLLKF's competition here
SMMNY vs EAPIF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, EAPIF has a market cap of 120.9M. Regarding current trading prices, SMMNY is priced at $20.44, while EAPIF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas EAPIF's P/E ratio is -0.84. In terms of profitability, SMMNY's ROE is +0.11%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, SMMNY is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check EAPIF's competition here
SMMNY vs AMEUF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, SMMNY is priced at $20.44, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, SMMNY's ROE is +0.11%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, SMMNY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check AMEUF's competition here
SMMNY vs SOMNF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SOMNF has a market cap of 111.7M. Regarding current trading prices, SMMNY is priced at $20.44, while SOMNF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SOMNF's P/E ratio is -51.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, SMMNY is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check SOMNF's competition here
SMMNY vs BCCOY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, BCCOY has a market cap of 103.6M. Regarding current trading prices, SMMNY is priced at $20.44, while BCCOY trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas BCCOY's P/E ratio is -0.62. In terms of profitability, SMMNY's ROE is +0.11%, compared to BCCOY's ROE of -0.50%. Regarding short-term risk, SMMNY is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check BCCOY's competition here
SMMNY vs AVHHL Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, AVHHL has a market cap of 99.4M. Regarding current trading prices, SMMNY is priced at $20.44, while AVHHL trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas AVHHL's P/E ratio is -2.22. In terms of profitability, SMMNY's ROE is +0.11%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, SMMNY is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check AVHHL's competition here
SMMNY vs JMDMF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, SMMNY is priced at $20.44, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, SMMNY's ROE is +0.11%, compared to JMDMF's ROE of N/A. Regarding short-term risk, SMMNY is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check JMDMF's competition here
SMMNY vs RSHUF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, SMMNY is priced at $20.44, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, SMMNY's ROE is +0.11%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, SMMNY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check RSHUF's competition here
SMMNY vs CKMTF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, SMMNY is priced at $20.44, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, SMMNY's ROE is +0.11%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, SMMNY is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CKMTF's competition here
SMMNY vs SNZZF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, SMMNY is priced at $20.44, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas SNZZF's P/E ratio is -4.77. In terms of profitability, SMMNY's ROE is +0.11%, compared to SNZZF's ROE of -0.41%. Regarding short-term risk, SMMNY is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check SNZZF's competition here
SMMNY vs BLOZF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, BLOZF has a market cap of 67.6M. Regarding current trading prices, SMMNY is priced at $20.44, while BLOZF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas BLOZF's P/E ratio is -13.96. In terms of profitability, SMMNY's ROE is +0.11%, compared to BLOZF's ROE of -2.60%. Regarding short-term risk, SMMNY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check BLOZF's competition here
SMMNY vs TLTFF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, TLTFF has a market cap of 50.1M. Regarding current trading prices, SMMNY is priced at $20.44, while TLTFF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas TLTFF's P/E ratio is -19.50. In terms of profitability, SMMNY's ROE is +0.11%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, SMMNY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check TLTFF's competition here
SMMNY vs BRNHF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, SMMNY is priced at $20.44, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, SMMNY's ROE is +0.11%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, SMMNY is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check BRNHF's competition here
SMMNY vs RDGL Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, RDGL has a market cap of 40.9M. Regarding current trading prices, SMMNY is priced at $20.44, while RDGL trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas RDGL's P/E ratio is -8.99. In terms of profitability, SMMNY's ROE is +0.11%, compared to RDGL's ROE of -1.18%. Regarding short-term risk, SMMNY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check RDGL's competition here
SMMNY vs PYNKF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, PYNKF has a market cap of 35.3M. Regarding current trading prices, SMMNY is priced at $20.44, while PYNKF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas PYNKF's P/E ratio is 5.61. In terms of profitability, SMMNY's ROE is +0.11%, compared to PYNKF's ROE of -2.30%. Regarding short-term risk, SMMNY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check PYNKF's competition here
SMMNY vs NVYTF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, NVYTF has a market cap of 33.9M. Regarding current trading prices, SMMNY is priced at $20.44, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, SMMNY's ROE is +0.11%, compared to NVYTF's ROE of -0.73%. Regarding short-term risk, SMMNY is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check NVYTF's competition here
SMMNY vs IPDQF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, IPDQF has a market cap of 28.5M. Regarding current trading prices, SMMNY is priced at $20.44, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas IPDQF's P/E ratio is -1.40. In terms of profitability, SMMNY's ROE is +0.11%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, SMMNY is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check IPDQF's competition here
SMMNY vs POSC Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, POSC has a market cap of 27.4M. Regarding current trading prices, SMMNY is priced at $20.44, while POSC trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas POSC's P/E ratio is 0.39. In terms of profitability, SMMNY's ROE is +0.11%, compared to POSC's ROE of -3.78%. Regarding short-term risk, SMMNY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check POSC's competition here
SMMNY vs MKEAF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, SMMNY is priced at $20.44, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, SMMNY's ROE is +0.11%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, SMMNY is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check MKEAF's competition here
SMMNY vs KBBTF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, SMMNY is priced at $20.44, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, SMMNY's ROE is +0.11%, compared to KBBTF's ROE of N/A. Regarding short-term risk, SMMNY is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check KBBTF's competition here
SMMNY vs EMITF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, EMITF has a market cap of 20.1M. Regarding current trading prices, SMMNY is priced at $20.44, while EMITF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas EMITF's P/E ratio is -8.57. In terms of profitability, SMMNY's ROE is +0.11%, compared to EMITF's ROE of -0.14%. Regarding short-term risk, SMMNY is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check EMITF's competition here
SMMNY vs DIZTF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, SMMNY is priced at $20.44, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, SMMNY's ROE is +0.11%, compared to DIZTF's ROE of -0.72%. Regarding short-term risk, SMMNY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check DIZTF's competition here
SMMNY vs GTHP Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, GTHP has a market cap of 16.7M. Regarding current trading prices, SMMNY is priced at $20.44, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas GTHP's P/E ratio is -4.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to GTHP's ROE of +0.70%. Regarding short-term risk, SMMNY is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check GTHP's competition here
SMMNY vs ASAPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ASAPF has a market cap of 15.9M. Regarding current trading prices, SMMNY is priced at $20.44, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ASAPF's P/E ratio is -20.34. In terms of profitability, SMMNY's ROE is +0.11%, compared to ASAPF's ROE of -0.32%. Regarding short-term risk, SMMNY is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check ASAPF's competition here
SMMNY vs MDXHF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, SMMNY is priced at $20.44, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, SMMNY's ROE is +0.11%, compared to MDXHF's ROE of +0.58%. Regarding short-term risk, SMMNY is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check MDXHF's competition here
SMMNY vs VPTDF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VPTDF has a market cap of 14.3M. Regarding current trading prices, SMMNY is priced at $20.44, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VPTDF's P/E ratio is -4.14. In terms of profitability, SMMNY's ROE is +0.11%, compared to VPTDF's ROE of +1.07%. Regarding short-term risk, SMMNY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check VPTDF's competition here
SMMNY vs TMDIF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, SMMNY is priced at $20.44, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, SMMNY's ROE is +0.11%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, SMMNY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check TMDIF's competition here
SMMNY vs ATBPF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, SMMNY is priced at $20.44, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, SMMNY's ROE is +0.11%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, SMMNY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check ATBPF's competition here
SMMNY vs LXXGF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, SMMNY is priced at $20.44, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, SMMNY's ROE is +0.11%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, SMMNY is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check LXXGF's competition here
SMMNY vs RMSL Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, RMSL has a market cap of 10.6M. Regarding current trading prices, SMMNY is priced at $20.44, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas RMSL's P/E ratio is 0.66. In terms of profitability, SMMNY's ROE is +0.11%, compared to RMSL's ROE of -12.31%. Regarding short-term risk, SMMNY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check RMSL's competition here
SMMNY vs PMEDF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, PMEDF has a market cap of 8.5M. Regarding current trading prices, SMMNY is priced at $20.44, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas PMEDF's P/E ratio is -2.05. In terms of profitability, SMMNY's ROE is +0.11%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, SMMNY is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check PMEDF's competition here
SMMNY vs PLLWF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, SMMNY is priced at $20.44, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, SMMNY's ROE is +0.11%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, SMMNY is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check PLLWF's competition here
SMMNY vs ALRTF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ALRTF has a market cap of 7.5M. Regarding current trading prices, SMMNY is priced at $20.44, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ALRTF's P/E ratio is -0.30. In terms of profitability, SMMNY's ROE is +0.11%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, SMMNY is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check ALRTF's competition here
SMMNY vs USAQ Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, USAQ has a market cap of 6.4M. Regarding current trading prices, SMMNY is priced at $20.44, while USAQ trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas USAQ's P/E ratio is -14.25. In terms of profitability, SMMNY's ROE is +0.11%, compared to USAQ's ROE of +0.63%. Regarding short-term risk, SMMNY is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check USAQ's competition here
SMMNY vs ODYY Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ODYY has a market cap of 5.7M. Regarding current trading prices, SMMNY is priced at $20.44, while ODYY trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ODYY's P/E ratio is -1.14. In terms of profitability, SMMNY's ROE is +0.11%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, SMMNY is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check ODYY's competition here
SMMNY vs QLIS Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, SMMNY is priced at $20.44, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas QLIS's P/E ratio is 2.22. In terms of profitability, SMMNY's ROE is +0.11%, compared to QLIS's ROE of -0.60%. Regarding short-term risk, SMMNY is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check QLIS's competition here
SMMNY vs RHNMF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, SMMNY is priced at $20.44, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, SMMNY's ROE is +0.11%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, SMMNY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check RHNMF's competition here
SMMNY vs BIEL Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, BIEL has a market cap of 5.4M. Regarding current trading prices, SMMNY is priced at $20.44, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas BIEL's P/E ratio is N/A. In terms of profitability, SMMNY's ROE is +0.11%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, SMMNY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check BIEL's competition here
SMMNY vs ADMT Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ADMT has a market cap of 5.4M. Regarding current trading prices, SMMNY is priced at $20.44, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ADMT's P/E ratio is -8.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, SMMNY is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check ADMT's competition here
SMMNY vs NGMDF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, NGMDF has a market cap of 4.1M. Regarding current trading prices, SMMNY is priced at $20.44, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas NGMDF's P/E ratio is -1.81. In terms of profitability, SMMNY's ROE is +0.11%, compared to NGMDF's ROE of +0.34%. Regarding short-term risk, SMMNY is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check NGMDF's competition here
SMMNY vs VANIW Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, SMMNY is priced at $20.44, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VANIW's P/E ratio is N/A. In terms of profitability, SMMNY's ROE is +0.11%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, SMMNY is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check VANIW's competition here
SMMNY vs CYDX Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, CYDX has a market cap of 3.3M. Regarding current trading prices, SMMNY is priced at $20.44, while CYDX trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas CYDX's P/E ratio is 0.82. In terms of profitability, SMMNY's ROE is +0.11%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, SMMNY is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check CYDX's competition here
SMMNY vs VYCO Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VYCO has a market cap of 3M. Regarding current trading prices, SMMNY is priced at $20.44, while VYCO trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VYCO's P/E ratio is -9.00. In terms of profitability, SMMNY's ROE is +0.11%, compared to VYCO's ROE of +0.00%. Regarding short-term risk, SMMNY is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check VYCO's competition here
SMMNY vs FZMD Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, FZMD has a market cap of 2.6M. Regarding current trading prices, SMMNY is priced at $20.44, while FZMD trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas FZMD's P/E ratio is 1.17. In terms of profitability, SMMNY's ROE is +0.11%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, SMMNY is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check FZMD's competition here
SMMNY vs TBRIF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, TBRIF has a market cap of 2.2M. Regarding current trading prices, SMMNY is priced at $20.44, while TBRIF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas TBRIF's P/E ratio is -0.76. In terms of profitability, SMMNY's ROE is +0.11%, compared to TBRIF's ROE of +16.81%. Regarding short-term risk, SMMNY is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check TBRIF's competition here
SMMNY vs LLBO Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, LLBO has a market cap of 1.7M. Regarding current trading prices, SMMNY is priced at $20.44, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas LLBO's P/E ratio is N/A. In terms of profitability, SMMNY's ROE is +0.11%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, SMMNY is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check LLBO's competition here
SMMNY vs KLYG Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, KLYG has a market cap of 1.5M. Regarding current trading prices, SMMNY is priced at $20.44, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas KLYG's P/E ratio is -12.01. In terms of profitability, SMMNY's ROE is +0.11%, compared to KLYG's ROE of -1.24%. Regarding short-term risk, SMMNY is more volatile compared to KLYG. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check KLYG's competition here
SMMNY vs VRSEF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, VRSEF has a market cap of 1.4M. Regarding current trading prices, SMMNY is priced at $20.44, while VRSEF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas VRSEF's P/E ratio is 0.14. In terms of profitability, SMMNY's ROE is +0.11%, compared to VRSEF's ROE of +1.00%. Regarding short-term risk, SMMNY is more volatile compared to VRSEF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check VRSEF's competition here
SMMNY vs ESMC Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ESMC has a market cap of 1.2M. Regarding current trading prices, SMMNY is priced at $20.44, while ESMC trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ESMC's P/E ratio is -5.37. In terms of profitability, SMMNY's ROE is +0.11%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, SMMNY is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for SMMNY.Check ESMC's competition here
SMMNY vs UAHC Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, UAHC has a market cap of 1.1M. Regarding current trading prices, SMMNY is priced at $20.44, while UAHC trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas UAHC's P/E ratio is 0.53. In terms of profitability, SMMNY's ROE is +0.11%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, SMMNY is more volatile compared to UAHC. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check UAHC's competition here
SMMNY vs NUMD Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, NUMD has a market cap of 919K. Regarding current trading prices, SMMNY is priced at $20.44, while NUMD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas NUMD's P/E ratio is 1.10. In terms of profitability, SMMNY's ROE is +0.11%, compared to NUMD's ROE of +0.23%. Regarding short-term risk, SMMNY is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check NUMD's competition here
SMMNY vs ELXMF Comparison March 2026
SMMNY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMNY stands at 92B. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, SMMNY is priced at $20.44, while ELXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMNY currently has a P/E ratio of 18.58, whereas ELXMF's P/E ratio is -0.09. In terms of profitability, SMMNY's ROE is +0.11%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, SMMNY is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for SMMNY.Check ELXMF's competition here